Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
- A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
- Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)Active Not Recruiting
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Multiple Sclerosis
Belgium, Czechia, Greece, Netherlands, Poland +1 more
Sponsor: Merck Sharp & Dohme LLC
Cervical Cancer
United States, Argentina, Austria, Belgium, Brazil +22 more
- Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual DiseaseNot Yet Recruiting
Sponsor: Exelixis
Colorectal Cancer
- Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer · Solid Tumors · Programmed Cell Death-1 (PD1, PD-1) · Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
Japan
Sponsor: Daiichi Sankyo
Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasm Malignant
United States, Brazil, Chile, China, Germany +6 more
- Pneumococcal Carriage DurationRecruiting
Sponsor: University of Central Florida
Pneumococcal Carriage
United States
Sponsor: Dana-Farber Cancer Institute
Lymphoma · Histiocytic Sarcoma · Follicular Dendritic Cell Sarcoma · Interdigitating Dendritic Cell Sarcoma
United States
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Sponsor: Merck Sharp & Dohme LLC
Hypercholesterolemia · Familial Hypercholesterolemia
United States, Argentina, China, Colombia, Germany +9 more
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Non-cystic Fibrosis Bronchiectasis
United States, Italy, Spain, United Kingdom
Sponsor: Australia New Zealand Gynaecological Oncology Group
Ovarian Carcinosarcoma · Uterine Carcinosarcoma
Australia, Canada, United Kingdom
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.Active Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer
United States
- A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Sponsor: Washington University School of Medicine
Cancer of Head and Neck · Head and Neck Cancer · Neoplasms, Head and Neck · Carcinoma, Squamous Cell of Head and Neck
United States
Sponsor: Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
United States, Argentina, Australia, Belgium, Brazil +13 more
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Sponsor: Matthew Galsky
Muscle Invasive Bladder Urothelial Carcinoma
United States
- A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Hyperlipidemia
United States, Argentina, Australia, Brazil, Canada +6 more
- A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Hepatic Impairment (HI)
United States
- Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaActive Not Recruiting
Sponsor: Duke University
Metastatic Renal Cell Carcinoma
United States
- A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Healthy
Sponsor: Merck Sharp & Dohme LLC
Endometrial Cancer
United States, Argentina, Australia, Austria, Belgium +29 more
Sponsor: Daiichi Sankyo
Esophageal Squamous Cell Carcinoma
United States, Belgium, China, Denmark, France +12 more